NCT05350787View on ClinicalTrials.gov

Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With R/R B-ALL

PHASE1RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 18, 2022

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions
B-ALL
Interventions
BIOLOGICAL

ThisCART19A

ThisCART19A is a new type CAR-T cells therapy for patients with acute B-cell leukemia

Trial Locations (2)

310003

RECRUITING

The First Hospital of Zhejiang Medical Colleage Zhejiang University, Hangzhou

Unknown

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER